India to United States: Doxorubicin Export Trade Route
India has recorded 176 verified shipments of Doxorubicin exported to United States, representing a combined trade value of $18.7M USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $106.3K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 60% of total export value with 72 shipments worth $11.2M USD. On the buying side, SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest importer in United States with $3.2M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together control 82% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Doxorubicin corridor is one of India's established pharmaceutical export routes, with 176 shipments documented worth a combined $18.7M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's doxorubicin manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $106.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with doxorubicin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 34.9%, placing it at rank #13 among India's top doxorubicin export destinations globally.
On the import side, key buyers of Indian doxorubicin in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, DR REDDYS LABORATORIES,INC and 42 others. SUN PHARMACEUTICAL INDUSTRIES,INC. is the single largest importer with 13 shipments valued at $3.2M USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#13
- Annual growth+34.9%
- Demand growth+29.0%
- Regulatory ease84/100
Top 10 Indian Doxorubicin Exporters to United States
Showing top 10 of 18 Indian suppliers exporting Doxorubicin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $156.1K per shipment | 72 | $11.2M | 60.1% |
| 2 | DR REDDYS LABORATORIES LIMITED Avg $208.9K per shipment | 10 | $2.1M | 11.2% |
| 3 | DR.REDDY'S LABORATORIES LTD Avg $219.0K per shipment | 9 | $2.0M | 10.5% |
| 4 | DR.REDDY'S LABORATORIES LIMITED Avg $251.9K per shipment | 6 | $1.5M | 8.1% |
| 5 | MYLAN LABORATORIES LIMITED Avg $233.2K per shipment | 4 | $932.8K | 5.0% |
| 6 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $48.2K per shipment | 6 | $289.4K | 1.5% |
| 7 | CADILA HEALTHCARE LTD Avg $122.3K per shipment | 2 | $244.6K | 1.3% |
| 8 | ZYDUS LIFESCIENCES LIMITED Avg $102.6K per shipment | 2 | $205.1K | 1.1% |
| 9 | CADILA HEALTHCARE LIMITED Avg $205.0K per shipment | 1 | $205.0K | 1.1% |
| 10 | ATLAS ENTERPRISES Avg $321 per shipment | 31 | $10.0K | 0.1% |
This table shows the top 10 of 18 Indian companies exporting doxorubicin to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, DR.REDDY'S LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, CADILA HEALTHCARE LTD, ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, ATLAS ENTERPRISES. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 72 shipments worth $11.2M USD, giving it a 60% market share. The top 3 suppliers together account for 82% of the total trade value on this route.
Showing top 10 of 18 total Indian exporters on the India to United States Doxorubicin export route.
Top 10 Doxorubicin Importers in United States
Showing top 10 of 45 known buyers in United States receiving Doxorubicin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian doxorubicin in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, DR REDDYS LABORATORIES,INC, SUN PHARMACEUTICAL INDUSTRIES INC.,, RXCROSSROADS 3PL LLC, among 45 total buyers. The largest importer is SUN PHARMACEUTICAL INDUSTRIES,INC., accounting for $3.2M USD across 13 shipments — representing 17% of all doxorubicin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 13 | $3.2M | 17.2% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES INC | 22 | $2.7M | 14.5% |
| 3 | DR REDDYS LABORATORIES,INC | 8 | $2.3M | 12.5% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC., | 11 | $2.0M | 10.7% |
| 5 | RXCROSSROADS 3PL LLC | 7 | $1.2M | 6.6% |
| 6 | DR REDDYS LABORATORIES INC | 4 | $1.0M | 5.4% |
| 7 | SUN PHARMACEUTICAL INDUSTRIESINC. | 5 | $731.9K | 3.9% |
| 8 | NORTHSTAR RX LLC | 3 | $716.7K | 3.8% |
| 9 | MYLAN INSTITUTIONAL INC | 3 | $694.2K | 3.7% |
| 10 | NORTHSTAR RX LLC, | 2 | $482.2K | 2.6% |
Showing top 10 of 45 Doxorubicin importers in United States on this route.
Top 10 Doxorubicin Formulations Imported by United States
Showing top 10 of 122 product formulations shipped on the India to United States Doxorubicin route, ranked by trade value
United States imports a wide range of doxorubicin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 50MG/25ML (2MG/ML) SINGLE DOSE VIALS (2634 PACKS)NOS — accounts for $779.5K USD across 1 shipments. There are 122 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 50MG/25ML (2MG/ML) SINGLE DOSE VIALS (2634 PACKS)NOS | 1 | $779.5K | 4.2% |
| 2 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC | 3 | $695.6K | 3.7% |
| 3 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC | 3 | $657.1K | 3.5% |
| 4 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 2 MG ML 10 ML PACK 1 VIAL SAPCODE 1114339 | 1 | $568.2K | 3.0% |
| 5 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 50MG/25ML 2MG/ML SINGLE DOSE VIALS NORTHSTAR | 2 | $484.8K | 2.6% |
| 6 | DOXORUBICIN HCL LIPOSOME INJ 50MG/25ML | 3 | $466.0K | 2.5% |
| 7 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 2MG/ML, 25ML [1775 PACK X 1 VIAL] | 1 | $450.2K | 2.4% |
| 8 | DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 20MG/10ML (2MG/ML) SINGLE DOSE VIALS (4371 PACKS) | 1 | $442.4K | 2.4% |
| 9 | DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20 MG/10 ML (2 MG/ML) (ANDA-US-FZE) (NORTHSTAR) PACK : 1 VIAL S | 2 | $412.2K | 2.2% |
| 10 | DOXORUBICIN HCL LIPOSOME INJECTION 50 MG | 2 | $410.0K | 2.2% |
Showing top 10 of 122 Doxorubicin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 73 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's doxorubicin exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 72 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD — together account for 82% of total trade value on this route. The average shipment value of $106.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as doxorubicin hydrochloride liposome injec and doxorubicin hydrochloride liposome injec , suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest importer with 13 shipments worth $3.2M USD — representing 17% of all doxorubicin imports from India on this route. A total of 45 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $18.7M
- Avg. Shipment
- $106.3K
- Suppliers
- 18
- Buyers
- 45
- Transit (Sea)
- ~20 days
- Annual Growth
- +34.9%
Related Analysis
Reverse Direction
United States → India — Doxorubicin (Import)Other Doxorubicin Routes
Unlock the Full India to United States Doxorubicin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 176 shipments on this route.
Frequently Asked Questions — India to United States Doxorubicin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Doxorubicin to United States?
The leading Indian exporters of Doxorubicin to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 60% of total trade value on this route.
Q What is the total value of Doxorubicin exports from India to United States?
India exports Doxorubicin to United States worth approximately $18.7M USD across 176 recorded shipments. The average value per shipment is $106.3K USD.
Q Which ports does India use to ship Doxorubicin to United States?
The most active port of origin is SAHAR AIR with 73 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Doxorubicin?
The average transit time for Doxorubicin shipments from India to United States is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Doxorubicin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 34.9% with demand growth tracking at 29.0%. The route is ranked #13 among India's top Doxorubicin export destinations globally.
Q How many suppliers are active on the India to United States Doxorubicin route?
There are currently 18 active Indian suppliers exporting Doxorubicin to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 60% of total shipment value.
Q Who are the main importers of Doxorubicin from India in United States?
The leading importers of Indian Doxorubicin in United States include SUN PHARMACEUTICAL INDUSTRIES,INC., SUN PHARMACEUTICAL INDUSTRIES INC, DR REDDYS LABORATORIES,INC, SUN PHARMACEUTICAL INDUSTRIES INC.,, RXCROSSROADS 3PL LLC. SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest buyer with 13 shipments worth $3.2M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Doxorubicin.
- 2.Supplier/Buyer Matching: 18 Indian exporters and 45 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 176 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
176 Verified Shipments
18 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists